Last reviewed: July 2, 2026
Last updated: July 2, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a GLP-1 receptor agonist that reduces appetite and improves blood sugar control, with clinical trials showing an average 15% body weight reduction over 68 weeks. Understanding how dosing works and why gradual increases matter is essential for safe, effective weight loss. PlexusDx makes personalized semaglutide therapy accessible without insurance, starting at $149 per month.
How Semaglutide Dosing Works for Weight Loss
Semaglutide treatment follows a titration schedule, meaning your dose increases gradually over several weeks. This approach minimizes nausea and other side effects while allowing your body to adapt to the medication. Most patients begin at 0.25 mg once weekly, then progress through 0.5 mg, 1.0 mg, and potentially 1.7 mg or 2.4 mg based on clinical response and tolerability.
The gradual dose increase is not arbitrary—it reflects how your gastrointestinal system and metabolic pathways respond to GLP-1 signaling. Higher doses produce stronger appetite suppression and improved glycemic control, but they also increase the likelihood of side effects like nausea or constipation if introduced too quickly. Your clinician monitors your progress and adjusts timing based on your individual response.
Typical Semaglutide Dosage Ranges and Timeline
Week 1–4: Patients typically inject 0.25 mg once per week to assess tolerance and establish baseline appetite reduction. Week 5–8: The dose increases to 0.5 mg weekly as the body adapts. Week 9–12: Most patients move to 1.0 mg weekly, which is often the effective maintenance dose for meaningful weight loss. Weeks 13 onward: Some patients advance to 1.7 mg or 2.4 mg weekly if needed for additional benefit, though many achieve their goals at 1.0 mg.
The timing between dose increases is flexible and depends on how well you tolerate each level. If you experience significant nausea or gastrointestinal discomfort, your clinician may extend the duration at each dose step or modify your dietary approach. PlexusDx coordinates with your medical provider to ensure your titration schedule matches your body's unique response pattern.
Why Semaglutide Dosage Matters for Weight Loss Results
Clinical evidence shows that dose-dependent outcomes exist: at 1.0 mg weekly, patients average 10–13% body weight loss, while the 2.4 mg dose produces approximately 15–17% reductions over comparable timeframes. However, the relationship between dose and results is not linear—some individuals achieve their target weight loss at lower doses, while others require higher amounts. Genetic factors, baseline metabolism, and adherence all influence the dose-response relationship.
PlexusDx offers the Precision Peptide Genetic Test to identify your genetic predispositions across key pathways: the GLP1R gene (rs6923761) influences how strongly you respond to GLP-1 signaling, while variants in MC4R and FTO genes affect appetite regulation and metabolic rate. Understanding your genetic profile helps your clinician predict whether you may need a higher or lower effective dose, personalizing your treatment from the start.
Semaglutide Pricing and Access at PlexusDx
PlexusDx compounded semaglutide injections start at $149 per month, with pricing that remains flat regardless of your dose level—whether you begin at 0.25 mg or eventually reach 2.4 mg. This flat-rate model ensures transparent costs and removes the financial uncertainty that often accompanies dose increases. No insurance is required, no membership fees apply, and your medication is shipped directly from a licensed 503A compounding pharmacy.
HSA and FSA accounts are accepted, making PlexusDx treatment even more accessible. After your first month of treatment, you have the option to add the Precision Peptide Genetic Test for $99, which maps 14 metabolic pathways and 150+ genetic insights to refine your long-term protocol. Many patients find that genetic data accelerates their progress by allowing earlier adjustments to their dose or medication choice.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical starting dose of semaglutide for weight loss?
Most weight loss programs begin with 0.25 mg injected once weekly. This introductory dose allows your body to adapt while minimizing nausea and gastrointestinal side effects. Your dose increases gradually every 1–4 weeks based on your tolerance and clinical response, with increases guided by your PlexusDx clinician.
How much weight can I expect to lose at different semaglutide doses?
At 1.0 mg weekly, average weight loss is 10–13% over 16–20 weeks. At 2.4 mg weekly, reductions typically reach 15–17% over similar timeframes. Individual results vary significantly based on genetics, lifestyle, starting weight, and medication adherence—your Precision Peptide Genetic Test helps predict your likely response range.
Does the price of PlexusDx semaglutide change when my dose increases?
No. PlexusDx semaglutide injections cost $149 per month flat across all dose levels. Your dose may need to go up, but your price won't—ensuring you never face surprise cost increases as your treatment progresses.
What side effects should I expect as my semaglutide dose increases?
Common side effects include nausea, constipation, vomiting, and reduced appetite, which typically peak during dose escalation and diminish over 1–2 weeks. Serious side effects are rare but may include pancreatitis or gallbladder issues. Gradual titration minimizes risk, and your PlexusDx clinician monitors your health throughout treatment.
How does the Precision Peptide Genetic Test help with semaglutide dosing?
The test identifies variants in GLP1R, GIPR, MC4R, and FTO genes that influence how strongly you respond to semaglutide and how quickly your metabolism adapts. This allows your clinician to predict whether you may benefit from faster dose escalation, higher maintenance doses, or a different GLP-1 medication entirely, personalizing your protocol from day one.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Ozempic: Understanding What Happens If You Take It Twice in One Week
Will Your Doctor Give You Ozempic for Weight Loss?